|
DGAP-Ad-hoc: JENOPTIK AG / Key word(s): Change in Forecast The Jenoptik Group achieved record figures in order intake, revenue and EBITDA in the 2nd quarter 2021. From April to June order intake almost doubled compared with the prior-year period, revenue grew by almost 30 percent and EBITDA by approx. 120 percent. In particular the very good development in the Light & Optics division, especially in the semiconductor equipment and biophotonics areas and by TRIOPTICS which is consolidated for the first time, contributed to this. In addition, the company saw recovery in the automotive industry. On the basis of the very positive operating performance the Executive Board now assumes that the existing guidance for revenue and EBITDA margin will be exceeded. For the fiscal year 2021, the Executive Board of JENOPTIK AG now anticipates an increase in revenue to 880 to 900 million euros (previously revenue growth in the low double-digit percentage range), and an EBITDA margin of between 19.0 and 19.5 percent (previously EBITDA margin of 16.0 - 17.0 percent). The Interim Report of JENOPTIK AG on the first half of 2021 will be published on August 11, 2021. If you have any further questions, please contact:
Contact: Leslie Iltgen Vice President Investor Relations & Communications Phone 03641-652291
15-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | JENOPTIK AG |
| Carl-Zeiss-Straße 1 | |
| 07743 Jena | |
| Germany | |
| Phone: | +49 (0)364 165-2156 |
| Fax: | +49 (0)364 165-2804 |
| E-mail: | ir@jenoptik.com |
| Internet: | www.jenoptik.com |
| ISIN: | DE000A2NB601 |
| WKN: | A2NB60 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1219411 |
| End of Announcement | DGAP News Service |
|
|
1219411 15-Jul-2021 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
